0001213900-23-075375.txt : 20230908 0001213900-23-075375.hdr.sgml : 20230908 20230908160034 ACCESSION NUMBER: 0001213900-23-075375 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230904 FILED AS OF DATE: 20230908 DATE AS OF CHANGE: 20230908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rothbard Jonathan B. CENTRAL INDEX KEY: 0001833968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38105 FILM NUMBER: 231245241 MAIL ADDRESS: STREET 1: 501 BEALE STREET STREET 2: UNIT 8D CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 180 Life Sciences Corp. CENTRAL INDEX KEY: 0001690080 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813832378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 EL CAMINO REAL STREET 2: BLDG 4, STE 200 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-507-0669 MAIL ADDRESS: STREET 1: 3000 EL CAMINO REAL STREET 2: BLDG 4, STE 200 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: KBL MERGER CORP. IV DATE OF NAME CHANGE: 20161115 4 1 ownership.xml OWNERSHIP DOCUMENT X0508 4 2023-09-04 0 0001690080 180 Life Sciences Corp. ATNF 0001833968 Rothbard Jonathan B. 3000 EL CAMINO REAL, BLDG. 4, SUITE 200 PALO ALTO CA 94306 0 1 0 0 Chief Scientific Officer 0 Common Stock 28023 D Stock Option (Right to Buy) 0.67 2023-09-04 4 A 0 15000 0.00 A 2033-09-04 Common Stock 15000 15000 D The Stock Options were granted to the Reporting Person pursuant to the Issuer's First Amended and Restated 2022 Omnibus Incentive Plan in consideration for services to be rendered as Chief Scientific Officer. Exempt from Section 16(b) pursuant to Rule 16b-3. The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. /s/ Jonathan B. Rothbard, Ph.D. 2023-09-08